Compile Data Set for Download or QSAR

Found 384 hits with Last Name = 'guan' and Initial = 'd'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Relaxin-3 receptor 1 (Homo sapiens (Human))	BDBM50605987 (CHEMBL5185575) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O |r| Show InChI	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	11	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1021/acs.jmedchem.2c00508 BindingDB Entry DOI: 10.7270/Q2S186MP
					More data for this Ligand-Target Pair
Relaxin-3 receptor 1 (Homo sapiens (Human))	BDBM50581019 (CHEMBL5089949) Show SMILES COC(=O)c1ccc(CCNC(=N)N\N=C\c2c[nH]c3c(C)cc(cc23)C#N)cc1 Show InChI	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	Article PubMed	69	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Displacement of [125I]R3/I5 from human RXFP3 expressed in human CHO-K1 cells incubated for 1 hr by microplate scintillation counting analysis				Citation and Details Article DOI: 10.1021/acs.jmedchem.1c01081 BindingDB Entry DOI: 10.7270/Q2ZK5MJP
					More data for this Ligand-Target Pair
Relaxin-3 receptor 1 (Homo sapiens (Human))	BDBM50581009 (CHEMBL5094670) Show SMILES COc1cc(C)c2[nH]cc(\C=N\NC(=N)NCCc3ccc(cc3)C#N)c2c1 Show InChI	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	268	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Displacement of [125I]R3/I5 from human RXFP3 expressed in human CHO-K1 cells incubated for 1 hr by microplate scintillation counting analysis				Citation and Details Article DOI: 10.1021/acs.jmedchem.1c01081 BindingDB Entry DOI: 10.7270/Q2ZK5MJP
					More data for this Ligand-Target Pair
Relaxin-3 receptor 1 (Homo sapiens (Human))	BDBM50526409 (CHEMBL4522365) Show SMILES CCc1cc(O)cc2c(\C=N\NC(=N)NCCc3ccc(Cl)cc3)c[nH]c12 Show InChI InChI=1S/C20H22ClN5O/c1-2-14-9-17(27)10-18-15(11-24-19(14)18)12-25-26-20(22)23-8-7-13-3-5-16(21)6-4-13/h3-6,9-12,24,27H,2,7-8H2,1H3,(H3,22,23,26)/b25-12+	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem	Article PubMed	274	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Displacement of [125I]R3/I5 from human RXFP3 expressed in human CHO-K1 cells incubated for 1 hr by microplate scintillation counting analysis				Citation and Details Article DOI: 10.1021/acs.jmedchem.1c01081 BindingDB Entry DOI: 10.7270/Q2ZK5MJP
					More data for this Ligand-Target Pair
Relaxin-3 receptor 1 (Homo sapiens (Human))	BDBM50526408 (CHEMBL4586446) Show SMILES COc1cc(C)c2[nH]cc(\C=N\NC(=N)NCCc3ccc(Cl)c(Cl)c3)c2c1 Show InChI InChI=1S/C20H21Cl2N5O/c1-12-7-15(28-2)9-16-14(10-25-19(12)16)11-26-27-20(23)24-6-5-13-3-4-17(21)18(22)8-13/h3-4,7-11,25H,5-6H2,1-2H3,(H3,23,24,27)/b26-11+	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.51E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Displacement of [125I]R3/I5 from human RXFP3 expressed in human CHO-K1 cells incubated for 1 hr by microplate scintillation counting analysis				Citation and Details Article DOI: 10.1021/acs.jmedchem.1c01081 BindingDB Entry DOI: 10.7270/Q2ZK5MJP
					More data for this Ligand-Target Pair
Sigma intracellular receptor 2 (Homo sapiens (Human))	BDBM50606009 (CHEMBL5207128) Show SMILES Clc1ccc(cc1)-c1noc(n1)-c1ccc(NC(=O)C2CN(Cc3ccco3)C(=O)C2)cc1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	Article PubMed	3.20E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1021/acs.jmedchem.2c00508 BindingDB Entry DOI: 10.7270/Q2S186MP
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM357253 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES CCn1cc(cn1)-c1ccc2cc([nH]c2c1)C(=O)c1cnn(c1N)-c1ccc2[nH]c(nc2c1)C1CC1 Show InChI InChI=1S/C27H24N8O/c1-2-34-14-18(12-29-34)16-5-6-17-10-24(31-22(17)9-16)25(36)20-13-30-35(26(20)28)19-7-8-21-23(11-19)33-27(32-21)15-3-4-15/h5-15,31H,2-4,28H2,1H3,(H,32,33)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.700	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
High affinity nerve growth factor receptor (Homo sapiens (Human))	BDBM158154 (US10081622, Compound 11 | US10370379, Entrectinib ...) Show SMILES CN1CCN(CC1)c1ccc(C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)c(NC2CCOCC2)c1 Show InChI InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem Similars	PDB Article PubMed	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of TRKA (unknown origin) by radiometric assay				Citation and Details Article DOI: 10.1016/j.bmcl.2021.128409 BindingDB Entry DOI: 10.7270/Q2CZ3C28
					More data for this Ligand-Target Pair				3D Structure (crystal)
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443226 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C)ncn2)c1Cl Show InChI InChI=1S/C30H36Cl2N8O4/c1-7-26(41)36-21-14-19(40-12-10-18(11-13-40)38(2)3)8-9-20(21)35-24-16-25(34-17-33-24)39(4)30(42)37-29-27(31)22(43-5)15-23(44-6)28(29)32/h7-9,14-18H,1,10-13H2,2-6H3,(H,36,41)(H,37,42)(H,33,34,35)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443226 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C)ncn2)c1Cl Show InChI InChI=1S/C30H36Cl2N8O4/c1-7-26(41)36-21-14-19(40-12-10-18(11-13-40)38(2)3)8-9-20(21)35-24-16-25(34-17-33-24)39(4)30(42)37-29-27(31)22(43-5)15-23(44-6)28(29)32/h7-9,14-18H,1,10-13H2,2-6H3,(H,36,41)(H,37,42)(H,33,34,35)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443223 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES CCN1CCC2(CN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)CC1 Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-17-32(18-42)10-12-41(7-2)13-11-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443223 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES CCN1CCC2(CN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)CC1 Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-17-32(18-42)10-12-41(7-2)13-11-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Mus musculus (Mouse))	BDBM109275 (US8609622, 2) Show SMILES COc1ccc(Cc2cc(ccc2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)c(F)c1F |r| Show InChI InChI=1S/C21H21ClF2O7/c1-29-14-5-2-10(15(23)16(14)24)6-11-7-12(3-4-13(11)22)21-19(28)17(26)18(27)20(8-25,31-21)9-30-21/h2-5,7,17-19,25-28H,6,8-9H2,1H3/t17-,18-,19+,20+,21+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.42	n/a	n/a	n/a	n/a	n/a	n/a
Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. US Patent					Assay Description Inhibitory activity of the compounds using SGLT1 and SGLT2.				US Patent US8609622 (2013) BindingDB Entry DOI: 10.7270/Q2BC3X6H
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Mus musculus (Mouse))	BDBM109278 (US8609622, 5) Show SMILES OC[C@]12COC(O1)([C@H](O)[C@@H](O)[C@@H]2O)c1ccc(Cl)c(Cc2ccc3OCCc3c2)c1 |r| Show InChI InChI=1S/C22H23ClO7/c23-16-3-2-15(9-14(16)8-12-1-4-17-13(7-12)5-6-28-17)22-20(27)18(25)19(26)21(10-24,30-22)11-29-22/h1-4,7,9,18-20,24-27H,5-6,8,10-11H2/t18-,19-,20+,21+,22?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.49	n/a	n/a	n/a	n/a	n/a	n/a
Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. US Patent					Assay Description Inhibitory activity of the compounds using SGLT1 and SGLT2.				US Patent US8609622 (2013) BindingDB Entry DOI: 10.7270/Q2BC3X6H
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443222 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC4(C3)CCNCC4)ncn2)c1Cl Show InChI InChI=1S/C31H36Cl2N8O4/c1-5-26(42)38-21-14-19(41-13-10-31(17-41)8-11-34-12-9-31)6-7-20(21)37-24-16-25(36-18-35-24)40(2)30(43)39-29-27(32)22(44-3)15-23(45-4)28(29)33/h5-7,14-16,18,34H,1,8-13,17H2,2-4H3,(H,38,42)(H,39,43)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443222 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC4(C3)CCNCC4)ncn2)c1Cl Show InChI InChI=1S/C31H36Cl2N8O4/c1-5-26(42)38-21-14-19(41-13-10-31(17-41)8-11-34-12-9-31)6-7-20(21)37-24-16-25(36-18-35-24)40(2)30(43)39-29-27(32)22(44-3)15-23(45-4)28(29)33/h5-7,14-16,18,34H,1,8-13,17H2,2-4H3,(H,38,42)(H,39,43)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443225 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES CCN1CCC2(CCN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)C1 Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-13-11-32(18-42)10-12-41(7-2)17-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.20	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443225 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES CCN1CCC2(CCN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)C1 Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-13-11-32(18-42)10-12-41(7-2)17-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.20	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443224 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES CCN1CCN(CC11CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1 Show InChI InChI=1S/C31H36Cl2N8O4/c1-6-26(42)37-21-14-19(40-12-13-41(7-2)31(17-40)10-11-31)8-9-20(21)36-24-16-25(35-18-34-24)39(3)30(43)38-29-27(32)22(44-4)15-23(45-5)28(29)33/h6,8-9,14-16,18H,1,7,10-13,17H2,2-5H3,(H,37,42)(H,38,43)(H,34,35,36)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.40	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443224 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES CCN1CCN(CC11CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1 Show InChI InChI=1S/C31H36Cl2N8O4/c1-6-26(42)37-21-14-19(40-12-13-41(7-2)31(17-40)10-11-31)8-9-20(21)36-24-16-25(35-18-34-24)39(3)30(43)38-29-27(32)22(44-4)15-23(45-5)28(29)33/h6,8-9,14-16,18H,1,7,10-13,17H2,2-5H3,(H,37,42)(H,38,43)(H,34,35,36)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.40	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443227 (N-(5-(4-Cyclopropylpiperazin-1-yl)-2-((6-(3-(2,6-d...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCN(CC3)C3CC3)ncn2)c1Cl Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-26(41)36-21-14-19(40-12-10-39(11-13-40)18-6-7-18)8-9-20(21)35-24-16-25(34-17-33-24)38(2)30(42)37-29-27(31)22(43-3)15-23(44-4)28(29)32/h5,8-9,14-18H,1,6-7,10-13H2,2-4H3,(H,36,41)(H,37,42)(H,33,34,35)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.5	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443227 (N-(5-(4-Cyclopropylpiperazin-1-yl)-2-((6-(3-(2,6-d...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCN(CC3)C3CC3)ncn2)c1Cl Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-26(41)36-21-14-19(40-12-10-39(11-13-40)18-6-7-18)8-9-20(21)35-24-16-25(34-17-33-24)38(2)30(42)37-29-27(31)22(43-3)15-23(44-4)28(29)32/h5,8-9,14-18H,1,6-7,10-13H2,2-4H3,(H,36,41)(H,37,42)(H,33,34,35)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.5	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM357251 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES Nc1c(cnn1-c1ccc2[nH]c(nc2c1)C1CC1)C(=O)c1cc2ccc(Br)cc2[nH]1 Show InChI InChI=1S/C22H17BrN6O/c23-13-4-3-12-7-19(26-17(12)8-13)20(30)15-10-25-29(21(15)24)14-5-6-16-18(9-14)28-22(27-16)11-1-2-11/h3-11,26H,1-2,24H2,(H,27,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.60	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
Acetyl-CoA carboxylase 1 (Homo sapiens (Human))	BDBM520084 ((R)-2-(6-cyano-1-(2-(2-ethoxy-5-fluoro-phenyl)-2-(...) Show SMILES CCOc1ccc(F)cc1[C@H](Cn1c2sc(C#N)c(C)c2c(=O)n(c1=O)C(C)(C)C(O)=O)OC1CCOCC1 |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.70	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The degree of inhibition of the enzymatic activity of recombinant human ACC1, ACC2 proteins under in-vitro conditions by the preferred compounds of t...				Citation and Details BindingDB Entry DOI: 10.7270/Q2N3014R
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM357252 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES Cn1cc(cn1)-c1ccc2cc([nH]c2c1)C(=O)c1cnn(c1N)-c1ccc2[nH]c(nc2c1)C1CC1 Show InChI InChI=1S/C26H22N8O/c1-33-13-17(11-28-33)15-4-5-16-9-23(30-21(16)8-15)24(35)19-12-29-34(25(19)27)18-6-7-20-22(10-18)32-26(31-20)14-2-3-14/h4-14,30H,2-3,27H2,1H3,(H,31,32)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.70	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
BDNF/NT-3 growth factors receptor (Homo sapiens (Human))	BDBM158154 (US10081622, Compound 11 | US10370379, Entrectinib ...) Show SMILES CN1CCN(CC1)c1ccc(C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)c(NC2CCOCC2)c1 Show InChI InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem Similars	Article PubMed	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of TRKB (unknown origin) by radiometric assay				Citation and Details Article DOI: 10.1016/j.bmcl.2021.128409 BindingDB Entry DOI: 10.7270/Q2CZ3C28
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Mus musculus (Mouse))	BDBM109277 (US8609622, 4) Show SMILES CCOc1ccc(Cc2cc(ccc2Cl)C23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1F |r| Show InChI InChI=1S/C22H24ClFO7/c1-2-29-17-6-3-12(8-16(17)24)7-13-9-14(4-5-15(13)23)22-20(28)18(26)19(27)21(10-25,31-22)11-30-22/h3-6,8-9,18-20,25-28H,2,7,10-11H2,1H3/t18-,19-,20+,21+,22?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.31	n/a	n/a	n/a	n/a	n/a	n/a
Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. US Patent					Assay Description Inhibitory activity of the compounds using SGLT1 and SGLT2.				US Patent US8609622 (2013) BindingDB Entry DOI: 10.7270/Q2BC3X6H
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Mus musculus (Mouse))	BDBM109275 (US8609622, 2) Show SMILES COc1ccc(Cc2cc(ccc2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)c(F)c1F |r| Show InChI InChI=1S/C21H21ClF2O7/c1-29-14-5-2-10(15(23)16(14)24)6-11-7-12(3-4-13(11)22)21-19(28)17(26)18(27)20(8-25,31-21)9-30-21/h2-5,7,17-19,25-28H,6,8-9H2,1H3/t17-,18-,19+,20+,21+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.65	n/a	n/a	n/a	n/a	n/a	n/a
Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. US Patent					Assay Description Inhibitory activity of the compounds using SGLT1 and SGLT2.				US Patent US8609622 (2013) BindingDB Entry DOI: 10.7270/Q2BC3X6H
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443228 (N-(5-(4-(Cyclopropyl(methyl)amino)piperidin-1-yl)-...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C3CC3)ncn2)c1Cl Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-28(43)38-23-15-21(42-13-11-20(12-14-42)40(2)19-7-8-19)9-10-22(23)37-26-17-27(36-18-35-26)41(3)32(44)39-31-29(33)24(45-4)16-25(46-5)30(31)34/h6,9-10,15-20H,1,7-8,11-14H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.80	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443228 (N-(5-(4-(Cyclopropyl(methyl)amino)piperidin-1-yl)-...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C3CC3)ncn2)c1Cl Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-28(43)38-23-15-21(42-13-11-20(12-14-42)40(2)19-7-8-19)9-10-22(23)37-26-17-27(36-18-35-26)41(3)32(44)39-31-29(33)24(45-4)16-25(46-5)30(31)34/h6,9-10,15-20H,1,7-8,11-14H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.80	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Acetyl-CoA carboxylase 1 (Homo sapiens (Human))	BDBM520082 (2-(6-Cyano-1-(2-(2-ethoxy-5-fluorophenyl)-2-((tetr...) Show SMILES CCOc1ccc(F)cc1C(Cn1c2sc(C#N)c(C)c2c(=O)n(c1=O)C(C)(C)C(O)=O)OC1CCOCC1 Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.40	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The degree of inhibition of the enzymatic activity of recombinant human ACC1, ACC2 proteins under in-vitro conditions by the preferred compounds of t...				Citation and Details BindingDB Entry DOI: 10.7270/Q2N3014R
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Mus musculus (Mouse))	BDBM109279 (US8609622, 7) Show SMILES OC[C@]12COC(O1)([C@H](O)[C@@H](O)[C@@H]2O)c1ccc(Cl)c(Cc2ccc(OCC(F)(F)F)cc2)c1 |r| Show InChI InChI=1S/C22H22ClF3O7/c23-16-6-3-14(22-19(30)17(28)18(29)20(9-27,33-22)10-32-22)8-13(16)7-12-1-4-15(5-2-12)31-11-21(24,25)26/h1-6,8,17-19,27-30H,7,9-11H2/t17-,18-,19+,20+,22?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.58	n/a	n/a	n/a	n/a	n/a	n/a
Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. US Patent					Assay Description Inhibitory activity of the compounds using SGLT1 and SGLT2.				US Patent US8609622 (2013) BindingDB Entry DOI: 10.7270/Q2BC3X6H
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443221 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCNC4(CC4)C3)ncn2)c1Cl Show InChI InChI=1S/C29H32Cl2N8O4/c1-5-24(40)36-19-12-17(39-11-10-34-29(15-39)8-9-29)6-7-18(19)35-22-14-23(33-16-32-22)38(2)28(41)37-27-25(30)20(42-3)13-21(43-4)26(27)31/h5-7,12-14,16,34H,1,8-11,15H2,2-4H3,(H,36,40)(H,37,41)(H,32,33,35)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.60	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443221 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCNC4(CC4)C3)ncn2)c1Cl Show InChI InChI=1S/C29H32Cl2N8O4/c1-5-24(40)36-19-12-17(39-11-10-34-29(15-39)8-9-29)6-7-18(19)35-22-14-23(33-16-32-22)38(2)28(41)37-27-25(30)20(42-3)13-21(43-4)26(27)31/h5-7,12-14,16,34H,1,8-11,15H2,2-4H3,(H,36,40)(H,37,41)(H,32,33,35)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.60	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 1 (Homo sapiens (Human))	BDBM357253 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES CCn1cc(cn1)-c1ccc2cc([nH]c2c1)C(=O)c1cnn(c1N)-c1ccc2[nH]c(nc2c1)C1CC1 Show InChI InChI=1S/C27H24N8O/c1-2-34-14-18(12-29-34)16-5-6-17-10-24(31-22(17)9-16)25(36)20-13-30-35(26(20)28)19-7-8-21-23(11-19)33-27(32-21)15-3-4-15/h5-15,31H,2-4,28H2,1H3,(H,32,33)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.90	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
NT-3 growth factor receptor (Homo sapiens (Human))	BDBM136597 (US10005783, 14 | US10047097, 14 | US10774085, Exam...) Show SMILES O[C@H]1CCN(C1)C(=O)Nc1cnn2ccc(nc12)N1CCC[C@@H]1c1cc(F)ccc1F |r| Show InChI InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of wild type TRKC (unknown origin)				Citation and Details Article DOI: 10.1016/j.bmcl.2021.128409 BindingDB Entry DOI: 10.7270/Q2CZ3C28
					More data for this Ligand-Target Pair
High affinity nerve growth factor receptor (Homo sapiens (Human))	BDBM136597 (US10005783, 14 | US10047097, 14 | US10774085, Exam...) Show SMILES O[C@H]1CCN(C1)C(=O)Nc1cnn2ccc(nc12)N1CCC[C@@H]1c1cc(F)ccc1F |r| Show InChI InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of wild type TRKA (unknown origin)				Citation and Details Article DOI: 10.1016/j.bmcl.2021.128409 BindingDB Entry DOI: 10.7270/Q2CZ3C28
					More data for this Ligand-Target Pair
BDNF/NT-3 growth factors receptor (Homo sapiens (Human))	BDBM136597 (US10005783, 14 | US10047097, 14 | US10774085, Exam...) Show SMILES O[C@H]1CCN(C1)C(=O)Nc1cnn2ccc(nc12)N1CCC[C@@H]1c1cc(F)ccc1F |r| Show InChI InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of wild type TRKB (unknown origin)				Citation and Details Article DOI: 10.1016/j.bmcl.2021.128409 BindingDB Entry DOI: 10.7270/Q2CZ3C28
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM357250 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES Nc1c(cnn1-c1ccc2[nH]c(nc2c1)C1CC1)C(=O)c1cc2ccc(F)cc2[nH]1 Show InChI InChI=1S/C22H17FN6O/c23-13-4-3-12-7-19(26-17(12)8-13)20(30)15-10-25-29(21(15)24)14-5-6-16-18(9-14)28-22(27-16)11-1-2-11/h3-11,26H,1-2,24H2,(H,27,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
NT-3 growth factor receptor (Homo sapiens (Human))	BDBM158154 (US10081622, Compound 11 | US10370379, Entrectinib ...) Show SMILES CN1CCN(CC1)c1ccc(C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)c(NC2CCOCC2)c1 Show InChI InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem Similars	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of TRKC (unknown origin) by radiometric assay				Citation and Details Article DOI: 10.1016/j.bmcl.2021.128409 BindingDB Entry DOI: 10.7270/Q2CZ3C28
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443220 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CC4(C3)CCNCC4)ncn2)c1Cl Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-25(41)37-20-12-18(40-15-30(16-40)8-10-33-11-9-30)6-7-19(20)36-23-14-24(35-17-34-23)39(2)29(42)38-28-26(31)21(43-3)13-22(44-4)27(28)32/h5-7,12-14,17,33H,1,8-11,15-16H2,2-4H3,(H,37,41)(H,38,42)(H,34,35,36)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
TBA US Patent					Assay Description The following method was used to determine the inhibition degree of the kinase activity of recombinant human FGFR protein by the compounds of the pre...				US Patent US11001572 (2021) BindingDB Entry DOI: 10.7270/Q2Z322RS
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM357254 (2-(5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-...) Show SMILES Nc1c(cnn1-c1ccc2[nH]c(nc2c1)C1CC1)C(=O)c1cc2ccc(cc2[nH]1)C#N Show InChI InChI=1S/C23H17N7O/c24-10-12-1-2-14-8-20(27-18(14)7-12)21(31)16-11-26-30(22(16)25)15-5-6-17-19(9-15)29-23(28-17)13-3-4-13/h1-2,5-9,11,13,27H,3-4,25H2,(H,28,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM443220 (N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...) Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CC4(C3)CCNCC4)ncn2)c1Cl Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-25(41)37-20-12-18(40-15-30(16-40)8-10-33-11-9-30)6-7-19(20)36-23-14-24(35-17-34-23)39(2)29(42)38-28-26(31)21(43-3)13-22(44-4)27(28)32/h5-7,12-14,17,33H,1,8-11,15-16H2,2-4H3,(H,37,41)(H,38,42)(H,34,35,36)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...				US Patent US10654836 (2020) BindingDB Entry DOI: 10.7270/Q25M68RT
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 1 (Homo sapiens (Human))	BDBM357251 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES Nc1c(cnn1-c1ccc2[nH]c(nc2c1)C1CC1)C(=O)c1cc2ccc(Br)cc2[nH]1 Show InChI InChI=1S/C22H17BrN6O/c23-13-4-3-12-7-19(26-17(12)8-13)20(30)15-10-25-29(21(15)24)14-5-6-16-18(9-14)28-22(27-16)11-1-2-11/h3-11,26H,1-2,24H2,(H,27,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
Acetyl-CoA carboxylase 2 (Homo sapiens (Human))	BDBM520084 ((R)-2-(6-cyano-1-(2-(2-ethoxy-5-fluoro-phenyl)-2-(...) Show SMILES CCOc1ccc(F)cc1[C@H](Cn1c2sc(C#N)c(C)c2c(=O)n(c1=O)C(C)(C)C(O)=O)OC1CCOCC1 |r| Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The degree of inhibition of the enzymatic activity of recombinant human ACC1, ACC2 proteins under in-vitro conditions by the preferred compounds of t...				Citation and Details BindingDB Entry DOI: 10.7270/Q2N3014R
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM357246 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES Nc1c(cnn1-c1ccc2[nH]c(nc2c1)C1CC1)C(=O)c1cc2ccccc2[nH]1 Show InChI InChI=1S/C22H18N6O/c23-21-15(20(29)19-9-13-3-1-2-4-16(13)25-19)11-24-28(21)14-7-8-17-18(10-14)27-22(26-17)12-5-6-12/h1-4,7-12,25H,5-6,23H2,(H,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.20	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Mus musculus (Mouse))	BDBM109277 (US8609622, 4) Show SMILES CCOc1ccc(Cc2cc(ccc2Cl)C23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1F |r| Show InChI InChI=1S/C22H24ClFO7/c1-2-29-17-6-3-12(8-16(17)24)7-13-9-14(4-5-15(13)23)22-20(28)18(26)19(27)21(10-25,31-22)11-30-22/h3-6,8-9,18-20,25-28H,2,7,10-11H2,1H3/t18-,19-,20+,21+,22?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6.35	n/a	n/a	n/a	n/a	n/a	n/a
Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. US Patent					Assay Description Inhibitory activity of the compounds using SGLT1 and SGLT2.				US Patent US8609622 (2013) BindingDB Entry DOI: 10.7270/Q2BC3X6H
					More data for this Ligand-Target Pair
Acetyl-CoA carboxylase 1 (Homo sapiens (Human))	BDBM520086 ((R)-2-(6-Cyano-1-(2-(5-fluoro-2-(2-fluoroethoxy)ph...) Show SMILES Cc1c(sc2n(C[C@H](OC3CCOCC3)c3cc(F)ccc3OCCF)c(=O)n(c(=O)c12)C(C)(C)C(O)=O)C#N |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.40	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The degree of inhibition of the enzymatic activity of recombinant human ACC1, ACC2 proteins under in-vitro conditions by the preferred compounds of t...				Citation and Details BindingDB Entry DOI: 10.7270/Q2N3014R
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 3 (Homo sapiens (Human))	BDBM357253 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) Show SMILES CCn1cc(cn1)-c1ccc2cc([nH]c2c1)C(=O)c1cnn(c1N)-c1ccc2[nH]c(nc2c1)C1CC1 Show InChI InChI=1S/C27H24N8O/c1-2-34-14-18(12-29-34)16-5-6-17-10-24(31-22(17)9-16)25(36)20-13-30-35(26(20)28)19-7-8-21-23(11-19)33-27(32-21)15-3-4-15/h5-15,31H,2-4,28H2,1H3,(H,32,33)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.80	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent					Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom...				US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Mus musculus (Mouse))	BDBM109277 (US8609622, 4) Show SMILES CCOc1ccc(Cc2cc(ccc2Cl)C23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1F |r| Show InChI InChI=1S/C22H24ClFO7/c1-2-29-17-6-3-12(8-16(17)24)7-13-9-14(4-5-15(13)23)22-20(28)18(26)19(27)21(10-25,31-22)11-30-22/h3-6,8-9,18-20,25-28H,2,7,10-11H2,1H3/t18-,19-,20+,21+,22?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6.92	n/a	n/a	n/a	n/a	n/a	n/a
Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. US Patent					Assay Description Inhibitory activity of the compounds using SGLT1 and SGLT2.				US Patent US8609622 (2013) BindingDB Entry DOI: 10.7270/Q2BC3X6H
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 384 total )  |  Next  |  Last  >>

Jump to: